Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for End Stage Renal Diseases
The 2025-2030 World Outlook for End Stage Renal Diseases This study covers the world outlook for end stage renal diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Psoriasis Medicines
The 2025-2030 World Outlook for Psoriasis Medicines This study covers the world outlook for psoriasis medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Dermatophytic Onychomycosis Therapeutics
The 2025-2030 World Outlook for Dermatophytic Onychomycosis Therapeutics This study covers the world outlook for dermatophytic onychomycosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Narcolepsy Drugs
The 2025-2030 World Outlook for Narcolepsy Drugs This study covers the world outlook for narcolepsy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Substance Abuse Therapeutics
The 2025-2030 World Outlook for Substance Abuse Therapeutics This study covers the world outlook for substance abuse therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for RNA-Based Therapeutics
The 2025-2030 World Outlook for RNA-Based Therapeutics This study covers the world outlook for RNA-based therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Treatments
The 2025-2030 World Outlook for Hepatitis C Treatments This study covers the world outlook for hepatitis c treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for RNA Therapeutics
The 2025-2030 World Outlook for RNA Therapeutics This study covers the world outlook for RNA therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Cardiovascular Therapeutics
The 2025-2030 World Outlook for Cardiovascular Therapeutics This study covers the world outlook for cardiovascular therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics This study covers the world outlook for cancer supportive care therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Cancer-Treating Drugs
The 2025-2030 World Outlook for Cancer-Treating Drugs This study covers the world outlook for cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Autism Spectrum Disorder Therapeutics
The 2025-2030 World Outlook for Autism Spectrum Disorder Therapeutics This study covers the world outlook for autism spectrum disorder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Autism Therapies
The 2025-2030 World Outlook for Autism Therapies This study covers the world outlook for autism therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Uveitis Drugs
The 2025-2030 World Outlook for Uveitis Drugs This study covers the world outlook for uveitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Ulcerative Colitis
The 2025-2030 World Outlook for Ulcerative Colitis This study covers the world outlook for ulcerative colitis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Type 1 Spinal Muscular Atrophy
The 2025-2030 World Outlook for Type 1 Spinal Muscular Atrophy This study covers the world outlook for type 1 spinal muscular atrophy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Inhalation and Nasal Spray Generic Corticosteroid Drugs
The 2025-2030 World Outlook for Inhalation and Nasal Spray Generic Corticosteroid Drugs This study covers the world outlook for inhalation and nasal spray generic corticosteroid drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Drugs
The 2025-2030 World Outlook for Breast Cancer Drugs This study covers the world outlook for breast cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Hereditary Angioedema Treatments
The 2025-2030 World Outlook for Hereditary Angioedema Treatments This study covers the world outlook for hereditary angioedema treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Guillain-Barre Syndrome Therapeutics
The 2025-2030 World Outlook for Guillain-Barre Syndrome Therapeutics This study covers the world outlook for guillain-Barre syndrome therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Progestogens for Cancer Cachexia
The 2025-2030 World Outlook for Progestogens for Cancer Cachexia This study covers the world outlook for progestogens for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Oral Anti Diabetes Drugs
The 2025-2030 World Outlook for Oral Anti Diabetes Drugs This study covers the world outlook for oral anti diabetes drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Antiepileptic Therapeutics for Fibromyalgia
The 2025-2030 World Outlook for Antiepileptic Therapeutics for Fibromyalgia This study covers the world outlook for antiepileptic therapeutics for fibromyalgia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Infectious Disease Drugs
The 2025-2030 World Outlook for Infectious Disease Drugs This study covers the world outlook for infectious disease drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Migraine Drugs
The 2025-2030 World Outlook for Migraine Drugs This study covers the world outlook for migraine drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
Research Assistance
